Boothbay Fund Management Portfolio holdings
Boothbay Fund Management is a multi-manager, multi-strategy alternative investment firm that mostly hands investors' money to portfolio managers rather than making the trades itself. It began operating in 2012 under its founder, Ari Glass, who oversees all of its activities. It favors emerging managers and niche strategies, often managers who have left larger institutions to start their own firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Tower
AMT
|
+$51.2M |
| 2 |
BP
BP
|
+$43.3M |
| 3 |
Digital Realty Trust
DLR
|
+$31.4M |
| 4 |
3M
MMM
|
+$27.6M |
| 5 |
Shell
SHEL
|
+$26.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Seagate
STX
|
+$38.9M |
| 2 |
Micron Technology
MU
|
+$28.3M |
| 3 |
GE Aerospace
GE
|
+$27.8M |
| 4 |
Terns Pharmaceuticals
TERN
|
+$25.6M |
| 5 |
Mineralys Therapeutics
MLYS
|
+$23.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 35.54% |
| 2 | Healthcare | 11.95% |
| 3 | Technology | 11.55% |
| 4 | Industrials | 8.81% |
| 5 | Consumer Discretionary | 7.7% |
Similar funds
Boothbay Fund Management's Q2 2026 Portfolio in Review
As of Q2 2026, Boothbay Fund Management held 2,785 positions worth $7.6B, down 1.5% from $7.71B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Boothbay Fund Management deployed $280M of net new capital in Q2 2026, opening 772 new positions and adding to 622 existing holdings. Its largest new stake was BP: 986,363 shares worth $36.4M.
By sector, the portfolio is most concentrated in Miscellaneous at 36% of assets, down from 48% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Seagate, an estimated $38.9M trimmed.
- Boothbay Fund Management's largest Q2 2026 buy was BP: 986,363 shares worth $36.4M.
- Boothbay Fund Management added most to American Tower in Q2 2026, an estimated $51.2M increase.
- Boothbay Fund Management's biggest Q2 2026 reduction was Seagate, cutting an estimated $38.9M.
- Boothbay Fund Management fully exited Terns Pharmaceuticals in Q2 2026, selling an estimated $25.6M.
- Boothbay Fund Management's ten largest holdings make up 18% of its $7.6B portfolio in Q2 2026.
- Boothbay Fund Management opened 772 new positions and closed 586 in Q2 2026.
- Boothbay Fund Management's portfolio value fell 1.5% quarter-over-quarter to $7.6B.
Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.